Supplemental Figure 2 from Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

Authors :: Raluca I. Verona
Michael Quigley
Iqbal S. Grewal
Szeman Ruby Chan
Andressa A. Smith
Douglas H. Yamada
Natasha M. Girgis
Karla R. Wiehagen
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: S2. CD45+ Immune infiltrate varies with immunotherapy, while frequencies of CD11b+ myeloid population are not significantly altered.

Full Text Access

Tools